Výsledky vyhledávání - "J. M. M. B. Otten"

Introduction of routine hepatitis B screening for all patients receiving cancer treatment

Autor: K, Leber, J M M B, Otten, A C T M, Depla, D P M, Brandjes, F N, Lauw

Publikováno v: The Netherlands journal of medicine. 77(1)

Background: Patients with a chronic hepatitis B virus (HBV) infection or patients who have recovered from an HBV infection are at risk for HBV reactivation (HBVr), especially if they need treatment with chemotherapy. International guidelines recommen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b111911dca649aa8d678f8cef6bfb8d3
https://pubmed.ncbi.nlm.nih.gov/30774100

Zobrazit plný text záznamu

Survival After Massive Ecstasy Overdose

Autor: Pieter L. Meenhorst, J. H. Beijnen, Robert A. A. Maes, J. M. M. B. Otten, D. de Boer, S. Ramcharan, C. H. W. Koks

Publikováno v: Journal of Toxicology: Clinical Toxicology. 36:727-731

Introduction: The toxicity profile of the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) is well known. This designer drug is usually taken at “house parties” and may cause severe complications, sometimes leading t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03eeae114ab0cc8299bde5782fc02035
https://doi.org/10.3109/15563659809162623

Zobrazit plný text záznamu

Combined dapsone and clofazimine intoxication

Autor: Jos H. Beijnen, J. M. M. B. Otten, Richard M. W. Hoetelmans, C. H. W. Koks, Marcel Soesan

Publikováno v: Human & Experimental Toxicology. 15:625-628

We report clinical findings and pharmacokinetic data regarding a combined dapsone and clofazimine intoxica tion in a man, who ingested 50 tablets of dapsone (100 mg), 20 capsules of clofazimine (100 mg) and two tablets of rifampicin (600 mg). Oral ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eea5a2935bd4444fbcb61cb43ab6e63
https://doi.org/10.1177/096032719601500805

Zobrazit plný text záznamu

Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism

Autor: A, Kleinjan, F F, van Doormaal, M H, Prins, H R, Büller, J M M B, Otten

Publikováno v: The Netherlands journal of medicine. 70(7)

Idiopathic venous thrombosis (IVT) is associated with occult malignancy in 10% of patients. The Trousseau study investigated whether extensive screening using abdominal and chest computed tomography (CT) scans and mammography in women would decrease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f4be9a367d093051376afacee6834022
https://pubmed.ncbi.nlm.nih.gov/22961824

Zobrazit plný text záznamu

Is extensive screening for cancer in idiopathic venous thromboembolism warranted?

Autor: S. M. van den Heiligenberg, R. van der Griend, Marten R. Nijziel, M.A. van de Ree, J. C. Dutilh, W. Terpstra, F.F. van Doormaal, H. R. Büller, J. M. M. B. Otten, Martin H. Prins, J van der Meer, A. J. ten Cate-Hoek

Publikováno v: Journal of Thrombosis and Haemostasis, 9(1), 79-84. Wiley
Journal of thrombosis and haemostasis, 9(1), 79-84. Wiley-Blackwell

Summary. Background: Patients with a first episode of idiopathic venous thromboembolism (IVTE) have an estimated 10% incidence of cancer within 12 months after diagnosis. However, the utility of screening for cancer in this population is controversia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34590893988a5fc3009478ef8adc0a5f
https://pubmed.ncbi.nlm.nih.gov/20946181

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání